1. Home
  2. FISI vs LXRX Comparison

FISI vs LXRX Comparison

Compare FISI & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FISI
  • LXRX
  • Stock Information
  • Founded
  • FISI 1817
  • LXRX 1995
  • Country
  • FISI United States
  • LXRX United States
  • Employees
  • FISI N/A
  • LXRX N/A
  • Industry
  • FISI Major Banks
  • LXRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • FISI Finance
  • LXRX Health Care
  • Exchange
  • FISI Nasdaq
  • LXRX Nasdaq
  • Market Cap
  • FISI 517.7M
  • LXRX 552.4M
  • IPO Year
  • FISI 1999
  • LXRX 2000
  • Fundamental
  • Price
  • FISI $29.23
  • LXRX $1.25
  • Analyst Decision
  • FISI Buy
  • LXRX Buy
  • Analyst Count
  • FISI 3
  • LXRX 5
  • Target Price
  • FISI $33.33
  • LXRX $3.23
  • AVG Volume (30 Days)
  • FISI 144.8K
  • LXRX 2.0M
  • Earning Date
  • FISI 10-23-2025
  • LXRX 11-06-2025
  • Dividend Yield
  • FISI 4.27%
  • LXRX N/A
  • EPS Growth
  • FISI N/A
  • LXRX N/A
  • EPS
  • FISI N/A
  • LXRX N/A
  • Revenue
  • FISI $116,735,000.00
  • LXRX $70,864,000.00
  • Revenue This Year
  • FISI $124.17
  • LXRX $66.55
  • Revenue Next Year
  • FISI $6.77
  • LXRX N/A
  • P/E Ratio
  • FISI N/A
  • LXRX N/A
  • Revenue Growth
  • FISI N/A
  • LXRX 1255.21
  • 52 Week Low
  • FISI $20.97
  • LXRX $0.28
  • 52 Week High
  • FISI $29.88
  • LXRX $1.66
  • Technical
  • Relative Strength Index (RSI)
  • FISI 61.80
  • LXRX 40.69
  • Support Level
  • FISI $28.00
  • LXRX $1.31
  • Resistance Level
  • FISI $29.25
  • LXRX $1.53
  • Average True Range (ATR)
  • FISI 0.63
  • LXRX 0.08
  • MACD
  • FISI 0.12
  • LXRX -0.02
  • Stochastic Oscillator
  • FISI 82.72
  • LXRX 18.57

About FISI Financial Institutions Inc.

Financial Institutions Inc operates as a financial holding company, engages in the provision of a wide range of consumer and commercial banking services to individuals, municipalities, and businesses in Western and Central New York. It operates through one segment: The Banking segment which includes all of the company's retail and commercial banking operations.

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

Share on Social Networks: